SCHEMBL6694189

SCHEMBL6694189

COc1ccc(Oc2c(Cl)c(F)nc(F)c2Cl)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB1 Q9H4B7 9/20 0.54
▸ TUBB4A P04350 7/20 0.54
▸ TUBB P07437 7/20 0.54
▸ TUBA3C P0DPH7 7/20 0.54
▸ TUBA1B P68363 7/20 0.54
▸ TUBA4A P68366 7/20 0.54
▸ TUBB4B P68371 7/20 0.54
▸ TUBB3 Q13509 7/20 0.54
▸ TUBB2A Q13885 7/20 0.54
▸ TUBB8 Q3ZCM7 7/20 0.54
▸ TUBA3E Q6PEY2 7/20 0.54
▸ TUBA1A Q71U36 7/20 0.54
▸ TUBA1C Q9BQE3 7/20 0.54
▸ TUBB6 Q9BUF5 7/20 0.54
▸ TUBB2B Q9BVA1 7/20 0.54
▸ APP P05067 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ RORC P51449 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ AOX1 Q06278 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6692393 0.84 THRB (0.39) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6693009 0.81 KDM4E (0.49) ALDH1A1MEN1LMNAHPGDKMT2A
SCHEMBL6694690 0.81 RORC (0.56) THRBRORC
SCHEMBL6692435 0.80 SMN1; SMN2 (0.39) ALDH1A1MEN1LMNAKMT2A
SCHEMBL6693303 0.80 TUBB1 (0.46) TUBB1ALDH1A1LMNA
SCHEMBL6694977 0.80 L3MBTL1 (0.42) ALDH1A1MEN1KMT2A
SCHEMBL6691486 0.78 ALDH1A1 (0.48) ALDH1A1MEN1KMT2A
SCHEMBL13518328 0.76 TUBB1 (0.79) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6692377 0.71 LMNA (0.58) THRBALDH1A1MEN1LMNAHPGD
SCHEMBL6697148 0.71 MAPK1 (0.37) THRBRORCALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6747048-B2 TREATING DISEASES OR DISORDERS ASSOCIATED WITH METABOLISM DYSFUNCTION OR WHICH ARE DEPENDENT UPON THE EXPRESSION OF A T3 REGULATED GENE, BRISTOL-MYERS SQUIBB COMPANY 2004-06-08 — — US disclosed
US-20040039028-A1 Pyridine-based thyroid receptor ligands BRISTOL-MYERS SQUIBB COMPANY 2004-02-26 — — US disclosed
WO-2003094845-A2 PYRIDINE-BASED THYROID RECEPTOR LIGANDS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-11-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039028-A1 Pyridine-based thyroid receptor ligands TSHR, THRB, THRA TUBB1 3607/4885TUBB4A 3977/4885TUBB 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback